Celltrion is spotlighted

Celltrion, the second largest KOSDAQ listed company, has been feted here in Korea, especially in the stock market as biosimilars are widely seen as a new engine of Korea’s economic growth. Samsung Group vowed to invest 500 billion won in it until 2014.

As the nation’s foremost biosimilar producer, Celltrion touts the largest market cap in value of all listed stocks on the KOSDAQ market at 4....